Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Benitec Biopharma Limited BNTC

Healthcare Biotechnology
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BNTC)

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update

GlobeNewswire November 14, 2025

Benitec Biopharma Inc. Announces Pricing of $100 Million Common Stock Offering

GlobeNewswire November 6, 2025

Benitec Biopharma Inc. Announces Proposed Public Offering

GlobeNewswire November 5, 2025

Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301

GlobeNewswire November 3, 2025

Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors

GlobeNewswire November 3, 2025

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy

GlobeNewswire November 2, 2025

Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update

GlobeNewswire September 22, 2025

Benitec Biopharma Provides Operational Updates

GlobeNewswire July 9, 2025

Benitec Biopharma Releases Third Quarter 2025 Financial Results

GlobeNewswire May 14, 2025
View More News ››

Opinion & Analysis (NDAQ:BNTC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BNTC)

Benitec Biopharma Inc. (NASDAQ:BNTC): A Promising Silence an

http://beyondspx.com/2024/08/02/benitec-biopharma-inc-nasdaqbntc-a-promising-silence-and-replace-approach-to-genetic-disorders/
MikeTester - August 3, 2024

BNTC.... Cha F'king Ching !!!

Thanks for the $'s
Iseneschal - August 9, 2023

BNTC.....RS # 5 ...LoL....recent P.O & RS

Show me the money !!!!
Iseneschal - August 9, 2023

BNTC.....2nd halt.....Yeeha !!!!!!!!!

Let rip again !!!!
Iseneschal - August 9, 2023
View more Bullboard ››

Pasofino Gold Limited

Pasofino Gold Limited

Pasofino Gold Limited, a Canada-based mineral exploration company, engages in the acquisition, exploration, and development ...
View More »